3 Stocks Under $10 Making Big Moves
SciClone Pharmaceuticals
SciClone Pharmaceuticals (SCLN) is a specialty pharmaceutical company with a product portfolio of therapies for oncology, infectious diseases, cardiovascular, urological, respiratory and central nervous system disorders. This stock is trading up 8.5% at $5.09 in recent trading.
Today's Range: $4.64-5.12
52-Week Range: $3.41-$7.58 Volume: 629,000 Three-Month Average Volume: 679,364 >>5 Rocket Stocks Ready for Blastoff From a technical perspective, SCLN is bouncing strong here right off some near-term support at $4.50 with decent volume. This move is quickly pushing SCLN within range of triggering a near-term breakout trade. That trade will hit once SCLN takes out some near-term overhead resistance at $5.18, and then its 50-day at $5.31 and its 200-day at $5.53 with high volume. Traders should now look for long-biased trades in SCLN as long as it's trending above $4.50, and then once it sustains a move or close above those breakout levels with volume that's near or above 679,364 shares. If that breakout triggers soon, then SCLN will have a great chance of re-testing or possibly taking out its next major overhead resistance levels at $5.99 to $6.04.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
